Press Releases
WASHINGTON, D.C. — Today, Congressman David Kustoff (R-TN) introduced the Restoring the Armed Career Criminal Act in the House of Representatives. This legislation will reinstate an important tool for prosecutors to seek enhanced penalties against violent, repeat offenders.
WASHINGTON, D.C. — Today, House Speaker Mike Johnson (R-LA) named Congressman David Kustoff (R-TN) Chairman of the House-Knesset Parliamentary Friendship Group for the 119th Congress.
WASHINGTON, D.C. — Congressman David Kustoff (R-TN) released the following statement after voting to pass the One Big Beautiful Bill in the House of Representatives:
WASHINGTON, D.C. — Today, Congressman David Kustoff (R-TN) and the entire Tennessee House Delegation introduced a Resolution in the House of Representatives to honor the founder, chairman, and CEO of FedEx Corporation, Frederick W. Smith.
WASHINGTON, D.C. — Today, Congressman David Kustoff (R-TN) honored the founder, chairman, and CEO of FedEx Corporation, Frederick W. Smith, on the Floor of the House of Representatives.
Memphis, TN. — Tonight, Rep. David Kustoff (TN-08) released the following statement regarding FedEx founder Fred Smith's passing.
WASHINGTON, D.C. — Today, Reps. David Kustoff (R-TN), Burgess Owens (R-UT), and Josh Harder (D-CA) introduced the NCAA Accountability Act of 2025 in the House of Representatives.
WASHINGTON, D.C. — Reps. David Kustoff (R-TN) and Bill Huizenga (R-MI) recently introduced the Clear the ROADS (Reckless Obstructions and Dangers on Streets) Act in the House of Representatives.
WASHINGTON, D.C. — Today, Congressman David Kustoff (R-TN) published an op-ed in the Washington Examiner titled, "The ‘one big, beautiful bill’ will restore the American dream." In the op-ed, Congressman Kustoff highlights the historic tax cuts in the One Big Beautiful Bill Act and lays out how they will jumpstart the economy.
WASHINGTON, D.C. — Reps. David Kustoff (R-TN) and August Pfluger (R-TX), as well as U.S. Senator Bill Cassidy, M.D. (R-LA), introduced the Small Biotech Innovation Act to exempt research and development-intensive small biotech manufacturers from the Medicare drug price negotiation program.